CASI Pharmaceuticals, Inc. (CASI) Financials

CASI Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 75.3 million 51.1 million
2023-09-30 74.2 million 23.8 million
2023-06-30 77.9 million 24.0 million
2023-03-31 88.4 million 26.2 million

CASI Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 ? 7.2 million
2023-09-30 ? ?
2023-06-30 ? ?
2023-03-31 -4.3 million 1.4 million

CASI Net Income

No data available :(

CASI Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 30.8 million - 2.3 million
2023-09-30 35.6 million - -
2023-06-30 38.8 million - -
2023-03-31 44.3 million - -

CASI Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 13.4 million
2023-09-30 13.4 million
2023-06-30 13.3 million
2023-03-31 13.3 million

CASI Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 - -1.9 million 6.4 million 5.2 million
2023-09-30 - 2.4 million 5.5 million 2.5 million
2023-06-30 - 2.6 million 7.7 million 4.8 million
2023-03-31 3.4 million 2.5 million 5.7 million 4.0 million

CASI Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 6.1 million 2.3 million
2023-09-30 8.8 million 3.6 million
2023-06-30 9.8 million 4.0 million
2023-03-31 8.3 million 3.4 million

CASI

Price: $2.42

52 week price:
1.85
8.48

Earnings Per Share: -2.02 USD

P/E Ratio: -2.08

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 21900

Ebitda: -1.6 million

Market Capitalization: 32.7 million

Links: